These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7073809)

  • 1. Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
    Leibsohn E
    J Int Med Res; 1982; 10(1):22-7. PubMed ID: 7073809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
    Shupack JL; Jondreau L; Kenny C; Stiller MJ
    Dermatology; 1993; 186(2):129-32. PubMed ID: 8428041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.
    Camarasa JM; Ortonne JP; Dubertret L
    J Dermatolog Treat; 2003 Jan; 14(1):8-13. PubMed ID: 12745849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of once-daily flurandrenolide tape versus twice-daily diflorasone diacetate ointment in the treatment of psoriasis.
    Krueger GG; O'Reilly MA; Weidner M; Dromgoole SH; Killey FP
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):186-90. PubMed ID: 9486672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
    Mensing H; Korsukewitz G; Yawalkar S
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1149-52. PubMed ID: 1757606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.
    Katz HI; Lindholm JS; Weiss JS; Shavin JS; Morman M; Bressinck R; Cornell R; Pariser DM; Pariser RJ; Weng W
    Clin Ther; 1995; 17(3):390-401. PubMed ID: 7585843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily treatment of psoriasis with topical glucocorticosteroid ointments.
    Lane AT; Wachs GN; Weston WL
    J Am Acad Dermatol; 1983 Apr; 8(4):523-5. PubMed ID: 6853785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
    Roberts DT
    Cutis; 1996 Feb; 57(2 Suppl):27-31. PubMed ID: 8646866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
    Anstey AV; Kragballe K
    Int J Dermatol; 2006 Aug; 45(8):970-5. PubMed ID: 16911387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
    van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J
    Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD
    Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis.
    Huntley AC; Isseroff R
    Cutis; 1985 May; 35(5):489-92. PubMed ID: 3891239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betamethasone dipropionate in optimized vehicle. Intermittent pulse dosing for extended maintenance treatment of psoriasis.
    Katz HI; Hien NT; Prawer SE; Scott JC; Grivna EM
    Arch Dermatol; 1987 Oct; 123(10):1308-11. PubMed ID: 3662562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of salicylic acid on the activity of betamethasone-17,21-dipropionate in the treatment of erythematous squamous dermatoses.
    Elie R; Durocher LP; Kavalec EC
    J Int Med Res; 1983; 11(2):108-12. PubMed ID: 6852357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis.
    Fowler JF; Hebert AA; Sugarman J
    J Drugs Dermatol; 2016 Feb; 15(2):154-62. PubMed ID: 26885782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.